Pharmacists and technicians New England Compounding Center are banned from getting similar jobs at other labs
(UPI) -- Pharmacists and technicians at a U.S. drug-compounding firm linked to a meningitis outbreak can't continue to work in the industry, state regulators said.
The Boston Globe obtained a copy of a letter the Massachusetts Board of Registration in Pharmacy sent to all pharmacists and pharmacy technicians employed by the New England Compounding Center in Framingham, Mass.
The letter stated that an investigation of the outbreak had determined the employees "may present an immediate or serious threat to the public health, safety, and welfare and should immediately cease," the Globe reported Tuesday.
Previously the board voted to seek the permanent surrender of the firm's pharmacy license as well as permanent revocation of the licenses of the company's three primary pharmacists, including co-owner Barry Cadden and his wife Lisa Conigliaro Cadden.
New England Compounding closed early last month and recalled all its products after a steroid produced at the company was linked to 30 deaths and 419 fungal meningitis cases.